These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 7384082

  • 21. Characterization of animal tumors: summary.
    Bogden AE.
    Prog Clin Biol Res; 1980; 37():303-10. PubMed ID: 7384089
    [No Abstract] [Full Text] [Related]

  • 22. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 23. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
    Weber KL, Pathak S, Multani AS, Price JE.
    J Urol; 2002 Aug 01; 168(2):774-9. PubMed ID: 12131367
    [Abstract] [Full Text] [Related]

  • 24. Acid phosphatase-producing androgen-independent subline of rat prostatic adenocarcinoma (Dunning R3327 tumor) in cell culture.
    Igarashi T, Isaka S, Miyauchi T, Hayata I, Shimazaki J.
    Prostate; 1984 Aug 01; 5(1):113-22. PubMed ID: 6694915
    [Abstract] [Full Text] [Related]

  • 25. Establishment of new human prostatic cancer cell line (JCA-1).
    Muraki J, Addonizio JC, Choudhury MS, Fischer J, Eshghi M, Davidian MM, Shapiro LR, Wilmot PL, Nagamatsu GR, Chiao JW.
    Urology; 1990 Jul 01; 36(1):79-84. PubMed ID: 2195744
    [Abstract] [Full Text] [Related]

  • 26. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
    Ruan HY, Li DR, Li L, Guan X, Zhang W.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul 01; 42(7):482-6. PubMed ID: 17961340
    [Abstract] [Full Text] [Related]

  • 27. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.
    Triest JA, Grignon DJ, Cher ML, Kocheril SV, Montecillo EJ, Talati B, Tekyi-Mensah S, Pontes JE, Hillman GG.
    Clin Cancer Res; 1998 Aug 01; 4(8):2009-14. PubMed ID: 9717832
    [Abstract] [Full Text] [Related]

  • 28. WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma.
    Pinthus JH, Waks T, Schindler DG, Harmelin A, Said JW, Belldegrun A, Ramon J, Eshhar Z.
    Cancer Res; 2000 Dec 01; 60(23):6563-7. PubMed ID: 11118033
    [Abstract] [Full Text] [Related]

  • 29. The Pollard tumors.
    Pollard M.
    Prog Clin Biol Res; 1980 Dec 01; 37():293-302. PubMed ID: 7384087
    [No Abstract] [Full Text] [Related]

  • 30. Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.
    Scatena CD, Hepner MA, Oei YA, Dusich JM, Yu SF, Purchio T, Contag PR, Jenkins DE.
    Prostate; 2004 May 15; 59(3):292-303. PubMed ID: 15042605
    [Abstract] [Full Text] [Related]

  • 31. The roles of epithelial-mesenchymal interactions and the innate immune response on the tumorigenicity of human prostate carcinoma cell lines grown in immuno-compromised mice.
    Frost GI, Dudouet B, Lustgarten J, Borgström P.
    In Vivo; 2003 May 15; 17(5):377-88. PubMed ID: 14598599
    [Abstract] [Full Text] [Related]

  • 32. In vivo models of human prostate cancer bone metastasis.
    Brown JM.
    Methods Mol Med; 2003 May 15; 81():149-62. PubMed ID: 12725119
    [No Abstract] [Full Text] [Related]

  • 33. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
    Mai KT, Yazdi HM, Farmer J.
    Prostate; 2001 May 15; 47(3):172-82. PubMed ID: 11351346
    [Abstract] [Full Text] [Related]

  • 34. [In vitro and in vivo models developed from human prostatic cancer].
    Bladou F, Gleave ME, Penault-Llorca F, Serment G, Lange PH, Vessella RL.
    Prog Urol; 1997 Jun 15; 7(3):384-96. PubMed ID: 9273065
    [Abstract] [Full Text] [Related]

  • 35. Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis.
    Tsui KH, Chang PL, Feng TH, Chung LC, Sung HC, Juang HH.
    Anticancer Res; 2008 Jun 15; 28(4A):1993-9. PubMed ID: 18649738
    [Abstract] [Full Text] [Related]

  • 36. [Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency].
    Song DX, Chen AM, Guo FJ, Liao H, Xie BZ, Zhu B, Chen C.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 29; 88(17):1197-201. PubMed ID: 18844116
    [Abstract] [Full Text] [Related]

  • 37. [Prostate and menadiol sodium diphosphate - menadiol sodium diphosphate as a new substrate for measuring acid phosphatase activity and a discussion on prostatic tumor model ].
    Fujino A.
    Nihon Hinyokika Gakkai Zasshi; 1982 Apr 29; 73(4):507-15. PubMed ID: 7120716
    [No Abstract] [Full Text] [Related]

  • 38. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET, Namiki M.
    Prostate; 2009 Aug 01; 69(11):1222-34. PubMed ID: 19434660
    [Abstract] [Full Text] [Related]

  • 39. Animal models of prostate cancer.
    Russell PJ, Voeks DJ.
    Methods Mol Med; 2003 Aug 01; 81():89-112. PubMed ID: 12725117
    [No Abstract] [Full Text] [Related]

  • 40. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH, Sun ZY, Meng XL, Wu JH, He GL, Liu GM, Jiang XR.
    Cancer Lett; 2006 Feb 20; 233(1):79-88. PubMed ID: 15885894
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.